Data on Umbralisib in Relapsed/Refractory Lymphoma

Data on Umbralisib in Relapsed/Refractory Lymphoma

obr

1 year
43 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Lori A. Leslie, MD, Hematologist-Oncologist, Lymphoma Department, John Theurer Cancer Center, Hackensack Meridian Health explains the results of the umbralisib phase II study involving patients with relapsed/refractory lymphoma.
Up Next Autoplay